Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
dupilumab [2025/04/18 20:40] – external edit 127.0.0.1dupilumab [2025/06/14 04:11] (current) – [Resources] Scott Larson
Line 15: Line 15:
  
 ==== Resources ==== ==== Resources ====
-{{::dupilumab-associated_ocular_manifestations-review_of_clinical_presentations_and_management_2022.pdf | Wu D et al. Dupilumab-associated ocular manifestations: A review of clinical presentations and managment. Surv Ophthalmol. 2022;67(5):1419-1422}}+[[https://1drv.ms/b/c/31d83ae8e55e0542/EW0RbSa-6SpHloMpdwjZYugBzs9tLRJYcJbgGCtykQccbw?e=tBGRwv | Wu D et al. Dupilumab-associated ocular manifestations: A review of clinical presentations and managment. Surv Ophthalmol. 2022;67(5):1419-1422]]
  
  
 {{tag>drugs}} {{tag>drugs}}